[(3R,5R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-[2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]ethyl-methylamino]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-(4-methylmorpholin-4-ium-4-yl)acetate

C56H77N2O5+ — CID 127040457

IUPAC[(3R,5R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-[2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]ethyl-methylamino]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-(4-methylmorpholin-4-ium-4-yl)acetate
SMILESCC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C(=O)CC[C@@H](C)[C@H]2CC[C@H]3[C@@H]4CC[C@@H]5C[C@H](OC(=O)C[N+]6(C)CCOCC6)CC[C@]5(C)[C@H]4CC[C@]23C)cc1)c1ccccc1
InChIInChI=1S/C56H77N2O5/c1-7-47(41-14-10-8-11-15-41)54(42-16-12-9-13-17-42)43-19-22-45(23-20-43)62-35-32-57(5)52(59)27-18-40(2)49-25-26-50-48-24-21-44-38-46(63-53(60)39-58(6)33-36-61-37-34-58)28-30-55(44,3)51(48)29-31-56(49,50)4/h8-17,19-20,22-23,40,44,46,48-51H,7,18,21,24-39H2,1-6H3/q+1/b54-47-/t40-,44-,46-,48+,49-,50+,51+,55+,56-/m1/s1
InChIKeyFQEGWJCUNJISPE-OOWFGFACSA-N
MW858.24 g/mol
LogP11.36
Rot. Bonds15

About [(3R,5R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-[2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]ethyl-methylamino]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-(4-methylmorpholin-4-ium-4-yl)acetate

[(3R,5R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-[2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]ethyl-methylamino]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-(4-methylmorpholin-4-ium-4-yl)acetate (PubChem CID 127040457) has the molecular formula C56H77N2O5+ and a molecular weight of 858.24 g/mol. Its IUPAC name is [(3R,5R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-[2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]ethyl-methylamino]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-(4-methylmorpholin-4-ium-4-yl)acetate.

Molecular Properties

Compound Name[(3R,5R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-[2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]ethyl-methylamino]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-(4-methylmorpholin-4-ium-4-yl)acetate
PubChem CID127040457
Molecular FormulaC56H77N2O5+
Molecular Weight858.24 g/mol
Exact Mass857.58
IUPAC Name[(3R,5R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-[2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]ethyl-methylamino]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-(4-methylmorpholin-4-ium-4-yl)acetate
SMILESCC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C(=O)CC[C@@H](C)[C@H]2CC[C@H]3[C@@H]4CC[C@@H]5C[C@H](OC(=O)C[N+]6(C)CCOCC6)CC[C@]5(C)[C@H]4CC[C@]23C)cc1)c1ccccc1
InChIInChI=1S/C56H77N2O5/c1-7-47(41-14-10-8-11-15-41)54(42-16-12-9-13-17-42)43-19-22-45(23-20-43)62-35-32-57(5)52(59)27-18-40(2)49-25-26-50-48-24-21-44-38-46(63-53(60)39-58(6)33-36-61-37-34-58)28-30-55(44,3)51(48)29-31-56(49,50)4/h8-17,19-20,22-23,40,44,46,48-51H,7,18,21,24-39H2,1-6H3/q+1/b54-47-/t40-,44-,46-,48+,49-,50+,51+,55+,56-/m1/s1
InChIKeyFQEGWJCUNJISPE-OOWFGFACSA-N
XLogP11.36
TPSA65.07 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds15
Heavy Atoms63
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500858.24
LogP ≤ 511.36
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'quaternary_nitrogen_2', 'substructure': 'N/A'}, {'alert_name': 'stilbene', 'substructure': 'N/A'}

Analyze [(3R,5R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-[2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]ethyl-methylamino]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-(4-methylmorpholin-4-ium-4-yl)acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(3R,5R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-[2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]ethyl-methylamino]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-(4-methylmorpholin-4-ium-4-yl)acetate?
The IUPAC name of [(3R,5R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-[2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]ethyl-methylamino]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-(4-methylmorpholin-4-ium-4-yl)acetate (CID 127040457) is [(3R,5R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-[2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]ethyl-methylamino]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-(4-methylmorpholin-4-ium-4-yl)acetate.
What is the SMILES notation for [(3R,5R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-[2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]ethyl-methylamino]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-(4-methylmorpholin-4-ium-4-yl)acetate?
The canonical SMILES for [(3R,5R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-[2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]ethyl-methylamino]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-(4-methylmorpholin-4-ium-4-yl)acetate is CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C(=O)CC[C@@H](C)[C@H]2CC[C@H]3[C@@H]4CC[C@@H]5C[C@H](OC(=O)C[N+]6(C)CCOCC6)CC[C@]5(C)[C@H]4CC[C@]23C)cc1)c1ccccc1.
What is the InChIKey of [(3R,5R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-[2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]ethyl-methylamino]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-(4-methylmorpholin-4-ium-4-yl)acetate?
The InChIKey is FQEGWJCUNJISPE-OOWFGFACSA-N. The full InChI is InChI=1S/C56H77N2O5/c1-7-47(41-14-10-8-11-15-41)54(42-16-12-9-13-17-42)43-19-22-45(23-20-43)62-35-32-57(5)52(59)27-18-40(2)49-25-26-50-48-24-21-44-38-46(63-53(60)39-58(6)33-36-61-37-34-58)28-30-55(44,3)51(48)29-31-56(49,50)4/h8-17,19-20,22-23,40,44,46,48-51H,7,18,21,24-39H2,1-6H3/q+1/b54-47-/t40-,44-,46-,48+,49-,50+,51+,55+,56-/m1/s1.
What are the key properties of [(3R,5R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-[2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]ethyl-methylamino]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-(4-methylmorpholin-4-ium-4-yl)acetate?
[(3R,5R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-[2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]ethyl-methylamino]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-(4-methylmorpholin-4-ium-4-yl)acetate has a molecular weight of 858.24 g/mol, XLogP of 11.36, 15 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for [(3R,5R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-[2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]ethyl-methylamino]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-(4-methylmorpholin-4-ium-4-yl)acetate is sourced from PubChem (CID 127040457), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).